Geneos Wealth Management Inc. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 3 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$839
-19.7%
1080.0%0.00%
Q2 2023$1,045
-11.7%
1080.0%0.00%
Q1 2023$1,1841080.0%0.00%
Q3 2022$0
-100.0%
108
-96.7%
0.00%
-100.0%
Q2 2022$36,000
-10.0%
3,233
-0.5%
0.00%0.0%
Q1 2022$40,000
-16.7%
3,250
+54.2%
0.00%0.0%
Q4 2021$48,000
+6.7%
2,1080.0%0.00%0.0%
Q3 2021$45,000
+1400.0%
2,108
+717.1%
0.00%
Q2 2021$3,000
-78.6%
258
-76.7%
0.00%
Q1 2021$14,000
+180.0%
1,1080.0%0.00%
Q4 2020$5,0001,1080.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders